Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT 48.60
+0.20 (0.41%)
At close: Jun 4, 2025
Navana Pharmaceuticals Revenue
Navana Pharmaceuticals had revenue of 2.24B BDT in the quarter ending March 31, 2025, with 28.13% growth. This brings the company's revenue in the last twelve months to 8.47B, up 30.23% year-over-year. In the fiscal year ending June 30, 2024, Navana Pharmaceuticals had annual revenue of 6.90B with 20.89% growth.
Revenue (ttm)
8.47B
Revenue Growth
+30.23%
P/S Ratio
0.62
Revenue / Employee
1.92M
Employees
4,408
Market Cap
5.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 6.90B | 1.19B | 20.89% |
| Jun 30, 2023 | 5.71B | 947.45M | 19.91% |
| Jun 30, 2022 | 4.76B | 1.15B | 31.95% |
| Jun 30, 2021 | 3.61B | 457.57M | 14.53% |
| Jun 30, 2020 | 3.15B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grameenphone | 157.46B |
| Square Pharmaceuticals PLC. | 75.86B |
| British American Tobacco Bangladesh Company | 98.15B |
| Robi Axiata PLC. | 97.75B |
| Walton Hi-Tech Industries | 78.24B |
| BRAC Bank PLC. | 65.27B |
| Bangladesh Export Import Company | 17.72B |
| Berger Paints Bangladesh | 27.70B |